(2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-((6-methoxy-2-oxo-2H-chromen-7-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid

Catalog No. :
ACNTZI746
CAS No. :
132752-65-9
Molecular Formula :
C16H16O10
Molecular Weight :
368.29

IUPAC Name:(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-((6-methoxy-2-oxo-2H-chromen-7-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid

(2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-((6-methoxy-2-oxo-2H-chromen-7-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2S,3S,4S,5R,6S)-3,4,5-Trihydroxy-6-((6-methoxy-2-oxo-2H-chromen-7-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
IUPAC Name(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-((6-methoxy-2-oxo-2H-chromen-7-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid
Molecular FormulaC16H16O10
Molecular Weight368.29
SMILESO=C1OC2=C(C=C(C(O[C@H]3[C@@H]([C@H]([C@@H]([C@@H](C(O)=O)O3)O)O)O)=C2)OC)C=C1
InChI KeyUTTLUAQBFYOVMO-JHZZJYKESA-N
Synonym6-Methoxy-2-oxo-2H-1-benzopyran-7-yl b-D-Glucopyranosiduronic Acid;Scopoletin b-D-Glucuronide;6-Methoxy-2-oxo-2H-1-benzopyran-7-yl -D-Glucopyranosiduronic Acid;Scopoletin -D-Glucuronide;β-D-Glucopyranosiduronic acid, 6-methoxy-2-oxo-2H-1-benzopyran-7-yl;Scopoletin β-D-Glucuronide
CAS No.132752-65-9

Synthetic Route by SureRoute

1. ACNTZI746 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACNTZI746 route product structure diagram
    ACNTZI746132752-65-9
Inquiry

2. ACNTZI746 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGRMY637 route compound structure diagram
    ACGRMY63792-61-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNTZI746 route product structure diagram
    ACNTZI746132752-65-9
Inquiry

Comments (0)